FDA Oncology shared on X:
An expert panel convened by FDA provides perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding – via Clinical Cancer Research.
First author – Jorge Cortes and last author- Kelly Norsworthy.”
Read further.
Source: FDA Oncology/X
Authors: Jorge E. Cortes, Elisabetta Abruzzese, Elyce H. Cardonick, Sonia Hernández-Díaz, Jamie Gutierrez, Mary S. Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C. Lerro, Brenda J. Gehrke, Stacy S. Shord, R. Angelo De Claro, Marc R. Theoret, Peter J. DeMaria, Kelly J. Norsworthy